Pages that link to "Q37255479"
Jump to navigation
Jump to search
The following pages link to Alefacept in the treatment of psoriasis (Q37255479):
Displaying 14 items.
- Cellular targeting in autoimmunity (Q26824580) (← links)
- Biologics in dermatologic therapy - an update (Q33607620) (← links)
- Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents (Q34112840) (← links)
- Selective Targeting of Human Alloresponsive CD8+ Effector Memory T Cells Based on CD2 Expression (Q34149246) (← links)
- Biologics in the management of psoriasis (Q34620257) (← links)
- Current status and future prospects for biologic treatments of psoriasis (Q36057909) (← links)
- Current and future immunomodulation strategies to restore tolerance in autoimmune diseases (Q36506677) (← links)
- Studies Introducing Costimulation Blockade for Vascularized Composite Allografts in Nonhuman Primates. (Q37031340) (← links)
- Pig embryonic pancreatic tissue as a source for transplantation in diabetes: transient treatment with anti-LFA1, anti-CD48, and FTY720 enables long-term graft maintenance in mice with only mild ongoing immunosuppression (Q37236287) (← links)
- Novel targeted therapies for autoimmunity (Q37614638) (← links)
- Biologics, an alternative therapeutic approach for oral lichen planus (Q37861278) (← links)
- Lessons From Pancreas Transplantation in Type 1 Diabetes: Recurrence of Islet Autoimmunity. (Q38627695) (← links)
- Biomarkers in pancreas transplant (Q38848032) (← links)
- Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells (Q59136962) (← links)